![Qasim Abbas](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von Qasim Abbas
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Creathor Venture Management GmbH
![]() Creathor Venture Management GmbH Investment ManagersFinance Creathor Venture Management GmbH is an independent private equity firm specialized in technology venture capital investing. Creathor was foundedi n 2003 and is headquartered in Bad Homburg near Frankfurt in central Germany. The management invests their own capital, and manages venture capital funds on behalf of institutions.
8
| Private Company | Investment Managers | 8 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Qasim Abbas
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
CEVEC Pharmaceuticals GmbH
![]() CEVEC Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology CEVEC Pharmaceuticals GmbH engages in the manufacture of biopharmaceuticals using a human cell-based expression system. It provides therapeutic proteins and monoclonal antibodies. The company was founded by Stefan Kochanek in 2004 and is headquartered in Cologne, Germany. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Future Capital
![]() Future Capital Investment ManagersFinance Future Capital (Future Capital) is an independent venture capital firm which was founded in 1999 as the initiative of the Hessen State Government and Hoechst AG (now Sanofi-Aventis Group). The firm is headquartered in Frankfurt, Germany. | Investment Managers | Chief Executive Officer | |
TACALYX GmbH
![]() TACALYX GmbH Miscellaneous Commercial ServicesCommercial Services TACALYX GmbH engages in the discovery and development of Tumor Associated Carbohydrate Antigenantibodies to treat cancer. The company was founded by Peter Sondermann, Peter H. Seeberger, and Oren Moscovitz and is headquartered in Berlin, Germany. | Miscellaneous Commercial Services | Director/Board Member | |
signals Invest GmbH
![]() signals Invest GmbH Investment ManagersFinance signals Invest GmbH (signals Venture Capital) is venture capital investment subsidiary of SIGNAL IDUNA Lebensversicherung AG, ultimately owned by SIGNAL IDUNA Gruppe, founded in 2017. The firm is headquartered in Berlin, Germany. | Investment Managers | Private Equity Investor | |
heal.capital Management GmbH
![]() heal.capital Management GmbH Investment ManagersFinance heal.capital Management GmbH (heal.capital) is an independent venture capital firm founded in 2019 and headquartered in Berlin, Germany. | Investment Managers | Private Equity Investor | |
BIOFRONTERA AG | Pharmaceuticals: Major | Director/Board Member | |
Cryotherapeutics SA
![]() Cryotherapeutics SA Medical SpecialtiesHealth Technology Cryotherapeutics SA develops and markets a cryotherapy system, with focus on highlighting the safety and efficacy of cryoneergy in the cardiovascular system. The firm specializes in the design of a proprietary system to be used in the treatment of coronary artery diseases that cause heart attacks. Its focus areas encompass technology research, system development, and early-stage product commercialization. The company was founded by Randell L. Werneth, John Yianni and Maurice Buchbinder on September 8, 2009 and is headquartered in Cologne, Germany. | Medical Specialties | Director/Board Member | |
Kelley School of Business | College/University | Masters Business Admin | |
Duale Hochschule Baden-Württemberg Mannheim | College/University | Undergraduate Degree | |
PROSTATYPE GENOMICS AB | Pharmaceuticals: Major | Director/Board Member | |
Chundsell Medicals AB
![]() Chundsell Medicals AB BiotechnologyHealth Technology Chundsell Medicals AB develops and markets novel molecular diagnostics for the treatment of cancer. Its product measures the expression pattern of selected embryonic stem cell genes in prostate cancer core needle biopsies. The company was founded by Sunne Rosell and Chunde Li in 2007 and is headquartered in Solna, Sweden. | Biotechnology | Director/Board Member | |
AYOXXA Biosystems GmbH
![]() AYOXXA Biosystems GmbH BiotechnologyHealth Technology AYOXXA Biosystems GmbH operates as a biotechnology firm. Its lunaris technology is the optimal analysis platform for the pre-clinical and clinical development work. The firm offers In-situ encoded bead array, a multiplexed protein analysis platform that allows users to measure proteins and biomolecular analytes. The company was founded by Dieter Trau and Andreas Schmidt in 2010 and is headquartered in Cologne, Germany. | Biotechnology | Director/Board Member | |
Phenex Pharmaceuticals AG
![]() Phenex Pharmaceuticals AG Pharmaceuticals: GenericHealth Technology Phenex Pharmaceuticals AG engages in the research and development of small molecule drugs focusing on the identification and analysis of selective drug candidates that target nuclear receptors. It also offers its resources and capabilities in the field of nuclear receptors to customers in the pharmaceutical and other life science industries. The company was founded by Claus Kremoser in 2002 and is headquartered in Ludwigshafen, Germany. | Pharmaceuticals: Generic | Director/Board Member | |
Sofialys SAS
![]() Sofialys SAS Information Technology ServicesTechnology Services Sofialys SAS provides mobile advertising and marketing solutions. Its products include direct marketing, display and branded marketplace. The company was founded by Mokhtar Bouchelaghem in 2003 and is headquartered in Paris, France. | Information Technology Services | Director/Board Member | |
Doodle AG
![]() Doodle AG Internet Software/ServicesTechnology Services Doodle AG engages in the development and licensing of software products. It also provides Internet-based services, particularly in the areas of user surveys and appointment coordination. The company was founded by Michael N?f and Paul E. Sevin? on March 2, 2007 and is headquartered in Zurich, Switzerland. | Internet Software/Services | Corporate Officer/Principal | |
vasopharm GmbH
![]() vasopharm GmbH Pharmaceuticals: MajorHealth Technology vasopharm GmbH operates as a pharmaceutical company. It discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases and their consequences. The firm focuses on therapeutics influencing the bioavailability of nitric oxide. The company was founded by Harald Schmidt and Ulrich Walter in July 1998 and is headquartered in Wuerzburg, Germany. | Pharmaceuticals: Major | Director/Board Member | |
Blueprint Genetics Oy
![]() Blueprint Genetics Oy BiotechnologyHealth Technology Blueprint Genetics Oy engages in the provision of genetic diagnostics and clinical interpretation of hereditary diseases. It offer dignistic tests for cardiology; dermatology; endocrinology; immunology; metabolic disorder; nephrology; and pulmonology. The company was founded by Tommi Pietari Lehtonen, Juha Koskenvuo, Tero-Pekka Alastalo, and Samuel Myllykangas in 2008 and is headquartered in Helsinki, Finland. | Biotechnology | Director/Board Member | |
Ludwig-Maximilians-Universität München | College/University | Masters Business Admin | |
Verve Capital Partners AG
![]() Verve Capital Partners AG Investment ManagersFinance Verve Capital Partners AG operates as investment company with interests in European startup companies. The company was founded by Steffen Wagner and Lukas Weber in 2010 and is headquartered in Baar, Switzerland. | Investment Managers | Private Equity Investor |
Statistik
International
Deutschland | 14 |
Vereinigte Staaten | 3 |
Schweden | 3 |
Schweiz | 3 |
Frankreich | 2 |
Sektoral
Health Technology | 11 |
Finance | 5 |
Consumer Services | 4 |
Technology Services | 4 |
Commercial Services | 2 |
Operativ
Director/Board Member | 14 |
Private Equity Investor | 8 |
Chief Executive Officer | 2 |
Masters Business Admin | 2 |
Chairman | 2 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Qasim Abbas
- Unternehmensverbindungen